Industry news

Successful First Edition of CPhI Russia Highlights Growth in Domestic Manufacturing and International Partnering

AsiaNet

CPhI Russia reflected growth in the Russian Pharma market at its debut next to IPhEB, the St Petersburg International Forum for Pharmacy, Medical  Equipment, Biotechnology and Radiology, and is the latest addition to UBM  Live's global pharmaceutical events portfolio. The event was held in St Petersburg on April 2013 and  brought together senior Russian pharma professionals and international  pharmaceutical suppliers and buyers.

Russian and US scientists launch type 2 diabetes drug program

Marchmont Innovation News

Russian and US researchers have launched a joint project aimed at developing an innovation drug candidate to fight type 2 diabetes, the website of Russia’s ChemRar biotech research company announced earlier this week.

Russian medical fraternity keen to forge ties with Indian counterparts

Business Line

Given the shortage of doctors, nurses and paramedics in the country as well as the rising cost of medical health services in the private sector, Health Minister Suresh Shetty has appealed to the private sector to join hands with the Government to provide charitable services for the needy.

WHO publications to be more actively translated into Russian - RF health minister

ITAR TASS

Publications of the World Health Organization (WHO) will be more actively translated into Russian, which will increase the accessibility of advanced knowledge in all the countries where people use it, Russian Health Minister Veronika Skvortsova said at an information event organised on the sidelines of the 66th World Health Assembly. It opened in Geneva on Monday. Russian is on the list of WHO official languages, along with English, Arabic, Spanish, Chinese and French. 

Chubais proposes to make Rusnano a private company by 2020

Venture News

The Chairman of the Board of Rusnano, JSC Anatoly Chubais has submitted a draft Strategy of the company development to the government, proposing to make Rusnano a fully private company by 2020. Rusnano’s revenue will amount to 500B RUR by that time according to the project on Strategies of the state-owned company. 

Analysis: Drugmakers face more scrutiny of discordant U.S. prices

Deena Beasley, Reuters

The world's biggest drug makers have for years enjoyed rich premiums for their medicines in the U.S. market. Those days may be coming to an end.

The Outlook for Medical Devices in Brazil, Russia, India & China

ReportLinker

Big drugmakers think small with nanomedicine deals

Ben Hirschler, Reuters

Is nanomedicine the next big thing? A growing number of top drug companies seem to think so.

Russian delegation’s participation in the forum BIO 2013 causes a huge interest

Life Sciences Leader

The Russian delegation took part in the world largest event for professionals of the biotechnology industry, the BIO International Convention 2013.

US-Russian Initiative in Life Science cooperation

Northern Biopharmaceutical Cluster

The Moscow Institute of Physics and Technology and the University of Wisconsin announce a non-exclusive consortium developing innovative therapeutics aimed at improvement of human and animal health.